Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 325, pseudogene (RN7SL325P)

Target
RN7SL325P
Molecular classification
Other (Pseudogene, Non-coding RNA fragment)
01

Overview

RN7SL325P refers to a specific **pseudogene** classified as "RNA, 7SL, cytoplasmic 325, pseudogene." Pseudogenes are defective copies or nonfunctional segments of genes that have lost their protein-coding ability or function through mutation, truncation, or other genomic rearrangements[1][5][3]. The “7SL RNA” component refers to the functional RNA moiety of the signal recognition particle (SRP), an essential ribonucleoprotein complex involved in targeting secretory proteins to the endoplasmic reticulum during translation[7][8]. However, RN7SL325P is not a functional gene, but an inactive genomic fragment derived from 7SL RNA. It is not known to be transcribed or translated, and is not implicated in any direct biological function or disease pathway[1][5][3]. RN7SL pseudogenes as a whole are highly numerous in the genome due to retrotransposition, but only a handful encode functional 7SL RNA[3][5]. There are no drugs, mechanisms of action, known disease associations, or biomarker roles for RN7SL325P. The inclusion of "pseudogene" and the lack of evidence for activity or biological relevance mean this is **not considered a therapeutic target**; it is essentially a nonfunctional genetic relic[1][5]. **Key notes:** - **This entity is not a receptor, enzyme, transporter, nor does it have a recognized physiological, pathological, or pharmacological role.** - The entry itself is not misspelled but is not a drug-discovery target. “Pseudogene” in the name indicates its nonfunctional nature. - Any references to 7SL RNA’s function are for the canonical, functional gene, not for this pseudogene copy.

Other names
RN7SL325P

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 325, pseudogene (RN7SL325P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 325, pseudogene (RN7SL325P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call